Or maybe cancer is quite a complex disease that requires a multitude of different advances that takes a long time, due to the need for patient recruitment, safety and efficacy proof via clinical trials. Cancer is heterogeneous, which means that it has different subtypes in the same cancer, hence why there is always a breadth of responses in each therapy.
unfortunately, until researchers and clinicians who trial new drugs can target the breadth of different genetic mutations, they need a broad therapy toxic drug that does unfortunately kill healthy cells. This is chemo.
- Forums
- ASX - By Stock
- Industry news
Or maybe cancer is quite a complex disease that requires a...
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.58 |
Change
0.055(3.62%) |
Mkt cap ! $268.4M |
Open | High | Low | Value | Volume |
$1.56 | $1.61 | $1.56 | $106.0K | 67.13K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 649 | $1.58 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.59 | 3000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 649 | 1.575 |
1 | 2868 | 1.570 |
1 | 325 | 1.540 |
1 | 1138 | 1.535 |
1 | 10000 | 1.525 |
Price($) | Vol. | No. |
---|---|---|
1.585 | 3000 | 1 |
1.620 | 2192 | 2 |
1.630 | 6499 | 2 |
1.640 | 4440 | 2 |
1.660 | 20000 | 1 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online